Table 2.
Pathobiologic features of sarcoidosis |
---|
• Highly polarized Th1 immunity at sites of disease |
• Oligoclonal T-cell expansions consistent with T-cell antigen-driven inflammation |
• Regulatory T-cell functional deficiency |
• Genetic susceptibility predominantly involving HLA genes within the MHC locus |
• Microbial triggers implicated in the etiology of a subset of sarcoidosis |
• Innate immune pathway dysregulation |
Pathobiologic questions in sarcoidosis |
• Role of specific microorganisms in sarcoidosis etiology and pathogenesis (e.g., mycobacteria, propionibacteria, others) |
• Role of active infection in sarcoidosis |
• Role of serum amyloid A aggregation in promoting chronic disease |
• Role of Th17 immunity in clinical phenotype |
• Role of Th1, Th17, and Th2 immune transition in fibrotic sarcoidosis |
Definition of abbreviations: HLA = human leukocyte antigen; MHC = major histocompatibility complex; Th = T helper cell.